Current Illinois CancerCare Clinical Trials

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

Study Number: GI008

Study Summary:
This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.

Status: Open

Study Coordinator(s)
  • Navigator Carrie, 309-243-3621, cmargis@illinoiscancercare.com
  • Drea, 309-243-3626 aogundipe@illinoiscancercare.com

Study Link

« Search Again